|
1 |
FDA Postpones Pixantrone Review Due to Severe Weather Conditions
|
Tuesday, 09 February 2010 |
M.E.Garza |
|
3 |
Trouble centers on China Biologic Products
|
Sunday, 07 February 2010 |
BioMedReports.Com |
|
4 |
Has MedaSorb found the Holy Grail which has eluded medicine for decades? [updated]
|
Saturday, 06 February 2010 |
M.E.Garza |
|
5 |
Recent Market Drops: Panic or Opportunity?
|
Saturday, 06 February 2010 |
Jude Santos & Wire Reports |
|
9 |
RxNews Recap for Thursday 02-04-10. Cyclacel (CYCC) jumps on upgrade
|
Thursday, 04 February 2010 |
Mary Davila |
|
10 |
Updated Executive Summary for Access Pharma (OTC: ACCP.OB)
|
Thursday, 04 February 2010 |
Mike Havrilla |
|
11 |
The LaboPharm Dump?
|
Thursday, 04 February 2010 |
Vinny Cassano |
|
13 |
BioSpecifics Technologies Announces FDA Approval of XIAFLEX
|
Tuesday, 02 February 2010 |
BioMedReports.Com |
|
15 |
Tapping Into Chinese Healthcare Reform Profits with an emerging American company
|
Tuesday, 02 February 2010 |
M.E.Garza |
|
17 |
Health Discovery Corporation (OTC:HDVY) Developments Update
|
Monday, 01 February 2010 |
Peter DePalma |
|
18 |
RxNews Recap for Friday 01-29-10. Mylan (MYL) gets FDA nod.
|
Friday, 29 January 2010 |
Mary Davila |
|
19 |
Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results
|
Friday, 29 January 2010 |
Staff and Wire Reports |
|
20 |
SIGA on target, plus Bio-Matrix and Adventrx's plays
|
Friday, 29 January 2010 |
Vinny Cassano |
